Anton Hoos

Director/Board Member en Patient Focused Medicine Development .

Consumer Services

Health Technology

Perfil

Anton Hoos is currently the Director at Patient Focused Medicine Development since 2014.
He was previously the Vice President at CSL Behring GmbH.
In 2023, he briefly served as the Chief Medical Officer, Head-Medical Affairs, R&D at Swedish Orphan Biovitrum AB.
Dr. Hoos holds an MBA from the University of Toronto and a doctorate from Ludwig-Maximilians-Universität München.

Cargos activos de Anton Hoos

Empresas	Cargo	Inicio
Patient Focused Medicine Development	Director/Board Member	01/01/2014

Todos los cargos activos de Anton Hoos

Antiguos cargos conocidos de Anton Hoos.

Empresas	Cargo	Fin
SWEDISH ORPHAN BIOVITRUM AB	Chief Tech/Sci/R&D Officer	19/06/2023
CSL Behring GmbH CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The private company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Anton Hoos.

Formación de Anton Hoos.

University of Toronto	Masters Business Admin
Ludwig-Maximilians-Universität München	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Anton Hoos.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SWEDISH ORPHAN BIOVITRUM AB	Health Technology

Empresas privadas	2
CSL Behring GmbH CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The private company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey.	Health Technology
Patient Focused Medicine Development

Ver las conexiones de la empresa